Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
In Silico and in Vivo Investigations of the Immunoreactivity of Klebsiella Pneumoniae Ompa Protein As a Vaccine Candidate Publisher Pubmed



Shahbazi S1 ; Badmasti F2 ; Habibi M1 ; Sabzi S1 ; Noori Goodarzi N3 ; Farokhi M4 ; Asadi Karam MR1
Authors

Source: Iranian biomedical journal Published:2024


Abstract

Background: The growing threat of antibiotic resistance and Klebsiella pneumoniae infection in healthcare settings highlights the urgent need for innovative solutions, such as vaccines, to address these challenges. This study sought to assess the potential of using K. pneumoniae outer membrane protein A (OmpA) as a vaccine candidate through both in silico and in vivo analyses. Methods: The study examined the OmpA protein sequence for subcellular localization, antigenicity, allergenicity, similarity to the human proteome, physicochemical properties, B-cell epitopes, MHC binding sites, tertiary structure predictions, molecular docking, and immune response simulations. The ompA gene was cloned into the pET-28a (+) vector, expressed, purified and confirmed using Western blotting analysis. IgG levels in the serum of the immunized mice were measured using ELISA with dilutions ranging from 1:100 to 1:6400, targeting recombinant outer membrane protein A (rOmpA) and K. pneumoniae ATCC 13883. The sensitivity and specificity of the ELISA method were also assessed. Results: The bioinformatics analysis identified rOmpA as a promising vaccine candidate. The immunized group demonstrated significant production of specific total IgG antibodies against rOmpA and K. pneumoniae ATCC1 13883, as compared to the control group (p < 0.0001). The titers of antibodies produced in response to bacterial exposure did not show any significant difference when compared to the anti-rOmpA antibodies (p > 0.05). The ELISA test sensitivity was 1:3200, and the antibodies in the serum could accurately recognize K. pneumoniae cells. Conclusion: This study is a significant advancement in the development of a potential vaccine against K. pneumoniae that relies on OmpA. Nevertheless, additional experimental analyses are required.
Related Docs
View other Related Docs
1. Defeating a Superbug: A Breakthrough in Vaccine Design Against Multidrug-Resistant Pseudomonas Aeruginosa Using Reverse Vaccinology, PLoS ONE (2023)
2. Epitope-Based Immunoinformatics Study of a Novel Pilq380–706-Pila Fusion Protein From Pseudomonas Aeruginosa, Gene Reports (2019)
3. Cbpm and Cbpg of Streptococcus Pneumoniae Elicit a High Protection in Mice Challenged With a Serotype 19F Pneumococcus, Iranian Journal of Allergy# Asthma and Immunology (2018)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Pourmand (3)
Abbas Bahador (2)
Other Related Docs
4. In Silico Design and Evaluation of Acinetobacter Baumannii Outer Membrane Protein a (Ompa) Antigenic Peptides As Vaccine Candidate in Immunized Mice, Iranian Journal of Allergy# Asthma and Immunology (2019)
5. Construction of a Chimeric Flic Including Epitopes of Ompa and Ompk36 As a Multi-Epitope Vaccine Against Klebsiella Pneumonia, Health Biotechnology and Biopharma (2021)
6. A Bioinformatics Approach to Introduce Novel Multi-Epitope Vaccines Against Acinetobacter Baumannii Retrieved From Immunogenic Extracellular Loops of Outer Membrane Proteins, Informatics in Medicine Unlocked (2022)
7. Subtractive Genomic Approach Toward Introduction of Novel Immunogenic Targets Against Clostridioides Difficile: Thinking Out of the Box, Microbial Pathogenesis (2022)
8. Identification and Molecular Characterization of Penicillin-Nonsusceptible Streptococcus Pneumoniae Isolates Recovered From Invasive Infections in a Pre-Pneumococcal Vaccine Era, Journal of Clinical Laboratory Analysis (2022)
9. Immunization With Bivalent Flagellin Protects Mice Against Fatal Pseudomonas Aeruginosa Pneumonia, Journal of Immunology Research (2017)
10. Serological Responses to a Soluble Recombinant Circumsporozoite Protein-Vk210 of Plasmodium Vivax (Rpvcsp-Vk210) Among Iranian Malaria Patients, European Journal of Medical Research (2021)
11. In Silico Design and Immunoinformatics Analysis of a Chimeric Vaccine Construct Based on Salmonella Pathogenesis Factors, Microbial Pathogenesis (2023)
12. Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia Chaffeensis, Applied Biochemistry and Biotechnology (2023)
13. Expression, Purification and Characterization of the Mixed Total-Omp-Caga From Brucella Abortus and Helicobacter Pylori As Vaccine Candidate, Journal of Pure and Applied Microbiology (2016)
14. Investigation of Novel Putative Immunogenic Targets Against Staphylococcus Aureus Using a Reverse Vaccinology Strategy, Infection# Genetics and Evolution (2021)
15. Designing and in Silico Analysis of Porb Protein From Chlamydia Trachomatis for Developing a Vaccine Candidate, Drug Research (2016)
16. Designing, Optimizing, and Structure Prediction of Chimeric Protein Ctb-Ipad for Expression in E.Coli, Biosciences Biotechnology Research Asia (2015)
17. The Combination of Cipa and Pbp-7/8 Proteins Contribute to the Survival of C57bl/6 Mice From Sepsis of Acinetobacter Baumannii, Microbial Pathogenesis (2021)
18. Assessment of a Poly-Epitope Candidate Vaccine Against Hepatitis B, C, and Poliovirus in Interaction With Monocyte-Derived Dendritic Cells: An Ex-Vivo Study, Human Immunology (2020)
19. Association Between Presence of Rmpa, Mrka and Mrkd Genes and Antibiotic Resistance in Clinical Klebsiella Pneumoniae Isolates From Hospitals in Tehran, Iran, Iranian Journal of Public Health (2021)
20. Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-Trna Synthetase As a New Target, Bioinformatics and Biology Insights (2023)